GlassScriptPhysician profile
Michael K Bokemper
NPI 1346668894
$4,010.14
in general payments reported to CMS, 2019-2025
9 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,277 · 2020: $248 · 2021: $1,906 · 2022: $70.20 · 2023: $224 · 2024: $158 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $2,121.53 | 2019-2023 | Xiaflex |
| Medical Device Business Services, INC. | $763.10 | 2019 | |
| Stryker Corporation | $506.27 | 2019-2025 | Easyfuse, Inbone, Anchorage |
| Axogen | $291.95 | 2019-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Smith+Nephew, INC. | $219.28 | 2021-2024 | Trigen Meta-Nail, Peri-Loc Vlp, Large Cannulated Screws |
| Linvatec Corporation | $50.50 | 2022-2024 | Biobrace 23mm |
| Endo USA, INC. | $23.87 | 2025 | Xiaflex |
| Bioventus LLC | $16.87 | 2021 | |
| Integra Lifesciences Corporation | $16.77 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bokemper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.